Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
33,060
Sort by:
Tuberculosis Treatment Drugs Industry Forecasts - China Focus
US$ 1,800.00
This study focuses on China’s Tuberculosis Treatment Drugs industry forecasts. In the two past decades, ... -term forecasts through 2023 and 2028 are presented. The primary and secondary research is done in China in ... focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find ...
September 2023
109 pages
Anesthetic Drugs Companies in China
US$ 1,800.00
This study focuses on China’s Anesthetic Drugs industry assessments and company profiles. In the two past decades, the industry has been ... 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our ...
September 2023
60 pages
Brain Cancer Treatment Drugs Companies in China
US$ 1,800.00
This study focuses on China’s Brain Cancer Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been ... 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our ...
September 2023
83 pages
Digestive Remedies Companies in China
US$ 1,800.00
This study focuses on China’s Digestive Remedies industry assessments and company profiles. In the two past decades, the industry has been ... 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our ...
September 2023
59 pages
Emerging Pharmaceuticals Companies in China
US$ 1,800.00
This study focuses on China’s Emerging Pharmaceuticals industry assessments and company profiles. In the two past decades, the industry has been ... 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our ...
September 2023
98 pages
Insulin Companies in China
US$ 1,800.00
This study focuses on China’s Insulin industry assessments and company profiles. In the two past decades, the industry has been ... 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our ...
September 2023
65 pages
Kidney Cancer Treatment Drugs Companies in China
US$ 1,800.00
This study focuses on China’s Kidney Cancer Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been ... 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our ...
September 2023
84 pages
Liver Cancer Treatment Drugs Companies in China
US$ 1,800.00
This study focuses on China’s Liver Cancer Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been ... 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our ...
September 2023
69 pages
Respiratory Drugs Companies in China
US$ 1,800.00
This study focuses on China’s Respiratory Drugs industry assessments and company profiles. In the two past decades, the industry has been ... 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our ...
September 2023
51 pages
Skin Cancer Treatment Drugs Companies in China
US$ 1,800.00
This study focuses on China’s Skin Cancer Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been ... 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our ...
September 2023
74 pages
Tuberculosis Treatment Drugs Companies in China
US$ 1,800.00
This study focuses on China’s Tuberculosis Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been ... 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our ...
September 2023
69 pages
Vaccine Adjuvants Market by Product (Emulsions, Pathogen, Saponin, Particulate), Route of administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Type ( Human vaccine , Veterinary vaccine) - Global Forecast to 2028
US$ 4,950.00
... product launches in the vaccine adjuvants market Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the vaccine adjuvants market Market Development: Comprehensive information about emerging markets. This report analyzes the market for various vaccine adjuvants across geographies Market Diversification: Exhaustive information about new products ...
September 2023
231 pages
Vitamin B Complex Ingredients Market Report by Type (Vitamin B1, Vitamin B2, Vitamin B3, Vitamin B5, Vitamin B6, Vitamin B7, Vitamin B9, Vitamin B12), Application (Pharmaceuticals, Foods and Beverages, Animal Feed), and Region 2023-2028
US$ 2,499.00
Market Overview: The global vitamin B complex ingredients market size reached US$ 2.99 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.03 Billion by 2028, exhibiting a...
September 2023
146 pages
Co-development Deals in Pharmaceuticals and Biotechnology 2016 to 2023
US$ 3,995.00
... including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche ...
September 2023
350 pages
Collaboration Deals in Pharmaceuticals 2019-2023
US$ 3,995.00
... including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche ...
September 2023
1000 pages
Distribution Deals in Pharmaceuticals and Biotechnology 2016 to 2023
US$ 3,995.00
... DESCRIPTION The Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019 report provides details of the latest distribution agreements announced in the pharmaceutical, biotechnology and ...
September 2023
500 pages
Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2023
US$ 3,995.00
... Joint venture alliances. KEY BENEFITS Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019 provides the reader with the following key benefits: In-depth understanding of joint venture partnering deal ...
September 2023
200 pages
Licensing Deals in Pharmaceuticals 2019-2023
US$ 3,995.00
... latest licensing agreements announced in the pharmaceutical, biotechnology ... licensing deals by value since 2014 Most active licensing dealmakers since 2014 The leading licensing partnering resources In Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014- 2019 available deals ...
September 2023
1200 pages
Royalty Rates in Pharmaceuticals and Biotechnology Deals
US$ 3,995.00
... including the technology licensed, royalty rates, license fees, upfront and milestone payments. DESCRIPTION The Global Royalty Rate Trends in Pharma ... licensed, royalty rates, license fees, upfront and milestone payments. This report provides details of the latest partnering deals which disclose a royalty rate ...
September 2023
500 pages
China Pharmaceutical Companies & Drugs Pipeline Insight 2023
US$ 6,600.00
Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. China Pharmaceutical Companies & Drugs Pipeline Insight 2023 Highlights:All Companies Are...
September 2023
2800 pages
Global Vitamin D Market 2023
US$ 2,950.00
The global vitamin D market is expected to rise by USD 76.3 million with a CAGR of 5.3% by the end of 2029. Key drivers of this growth include its application in nutricosmetics, premixes, functional b...
September 2023
89 pages
North American Drug Delivery Technologies Market: By Route of Administration (Oral Drug Delivery, Pulmonary Drug Delivery, Injectable Drug Delivery, Ocular Drug Delivery, Nasal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Transmucosal Drug Delivery), By Type (Advanced, Conventional), By Application (Disease Treatment, Research/Academic Purposes), By End User (Hospitals, Home Care Settings, Ambulatory Surgical Centers/Clinics, Others), And Region – Analysis of Market Size, Share & Trends For 2021–2022 And Forecasts To 2032
US$ 4,950.00
North American Drug Delivery Technologies Market: By Route of Administration (Oral Drug Delivery, Pulmonary Drug Delivery, Injectable Drug Delivery, Ocular Drug Delivery, Nasal Drug Delivery, Topical...
September 2023
398 pages
ADC Payload / Warheads Market: Distribution by Type of Product (Commercialized ADCs and Clinical ADCs), Type of Payload (Microtubule Inhibitors, DNA Damaging Agents, Topoisomerase Inhibitors and Others), Payload / Warhead (Auristatins, Calicheamicin, Camptothecin, Duocarmycin, Maytansinoids, Pyrrolobenzodiazepines and Others) and Geography (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2021-2035
US$ 4,799.00
ADC Payload / Warheads Market: Distribution by Type of Product (Commercialized ADCs and Clinical ADCs), Type of Payload (Microtubule Inhibitors, DNA Damaging Agents, Topoisomerase Inhibitors and Other...
September 2023
132 pages
AI in Drug Discovery Market (2nd Edition): Distribution by Drug Discovery Steps (Target Identification / Validation, Hit Generation / Lead Identification and Lead Optimization), Therapeutic Area (Oncological Disorders, CNS Disorders, Infectious Diseases, Respiratory Disorders, Cardiovascular Disorders, Endocrine Disorders, Gastrointestinal Disorders, Musculoskeletal Disorders, Immunological Disorders, Dermatological Disorders and Others) and Key Geographies (North America, Europe, Asia-Pacific, Latin America, MENA and Rest of the World): Industry Trends and Global Forecasts, 2022-2035
US$ 4,799.00
The AI in drug discovery market is expected to reach USD 0.74 billion by 2022 anticipated to grow at a CAGR of 25% during the forecast period 2022-2035. The journey of discovering and developing new t...
September 2023
387 pages
The Next Generation Drug Conjugates Market: Focus on GalNac Conjugate, Peptide Drug Conjugate, Peptide Oligonucleotide Conjugate, RNAi Conjugate, Peptide Receptor Radionuclide Therapy, Small Molecule-Drug Conjugate (SMDC), and Other Conjugates – Distribution by Type of Targeting Ligand (Amino Sugar, Lipid, Peptide, Small Molecule and Virus-like Particles), Type of Payload (Peptide, Small Molecule, Oligonucleotide and Radionuclide), Type of Therapy (Monotherapy and Combination Therapy), Route of Administration (Intravenous, Subcutaneous and Others), Mechanism of Action (sequence-specific target binding, radiation induced cytotoxicity, cancer-specific surface target mediated cytotoxicity, drug induced cytotoxicity, receptor mediated internalization and cytotoxicity and others) and Key Target Indications (Gastroenteropancreatic Neuroendocrine Tumors, Prostate Cancer, Leptomeningeal Carcinomatosis caused by Breast Cancer Brain Metastases, Hereditary Transthyretin Amyloidosis, Atherosclerotic Cardiovascular Diseases, Severe Hypertriglyceridemia, Hereditary Angioedema, Acute Hepatic Porphyria, Primary Hyperoxaluria, Heterozygous Familial Hypercholesterolemia, Hemophilia, Low-Risk Myelodysplastic Syndrome, Myelofibrosis, Alpha-1 Antitrypsin Deficiency Liver Disease and Familial Chylomicronemia Syndrome) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2023-2035
US$ 4,799.00
The global next generation drug conjugate market is anticipated to be valued at USD 15.47 billion in 2035 anticipated to grow at a CAGR of 18% during the forecast period 2023-2035. The next generation...
September 2023
120 pages
Plant Based Protein Expression Market by Type of Product (Biosimilars, Cell Therapies, Gene Therapies, Monoclonal Antibodies, Vaccines and Others), Type of Plant (Algae, Barley, Benth, Duckweed, Lettuce, Maize, Moss, Rice, Tomato, Tobacco and Wheat Germ), Type of Expression System (Stable Expression System and Transient Expression System), Type of Target Disease Indication (Cirrhotic Ascites, COVID-19, Cystic Fibrosis, Ebola Virus Infection, Fabry Disease, Gaucher Disease, Liver Cirrhosis, Influenza, and Peanut Allergy), Type of Therapeutic Area (Genetic Disorders, Infectious Disorders, Liver Disorders, Respiratory Disorders and Others), Drug (Elelyso, PALFORZIA, OsrHSA, PRX-102, Unnamed_1, Unnamed_2, PRX-110 and ZMapp), and Region (North America, Europe, Asia, Middle East and North Africa, Latin America and Rest of the World): Industry Trends and Global Forecasts, 2022-2035
US$ 4,799.00
The plant based protein expression market is expected to reach USD 1.3 billion in 2022 anticipated to grow at a CAGR of 11.9% during the forecast period 2022-2035. The increasing preference for biolog...
September 2023
155 pages
Vitamins China E-News 202308
US$ 3,186.00
... Dec. Issue of Vitamins China E-News. This newsletter will ... increasingly stringent environmental regulations in China. On 25 Dec., 2016, the first Environmental Protection Tax Law in China was approved ... were witnessed in prices of several vitamins, such as VC, calcium pantothenate, VB1 and VB12. As the ...
August 2023
40 pages
North America Neurotoxins Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product Type (Botox, Dysport, Xenomin, and Others), Application (Therapeutic and Aesthetic), and End User (Hospitals, Specialty Clinics, Dermatology Clinics, and Others)
US$ 3,000.00
The North America neurotoxins market is expected to grow from US$ 4,801.29 million in 2023 to US$ 8,416.95 million by 2028. It is estimated to grow at a CAGR of 11.9% from 2023 to 2028. Emergence of I...
August 2023
99 pages
Asia Pacific Medical Marijuana Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product Type (Dried Form and Extract Form), Application (Pain Management, Tourette’s, Alzheimer’s Disease, Migraines, Depression and Anxiety, Multiple Sclerosis, Cancer, and Others), and Distribution Channel (Retail Pharmacy, E-Commerce, and Others)
US$ 3,000.00
The Asia Pacific medical marijuana market is expected to grow from US$ 2,115.23 million in 2022 to US$ 6,203.80 million by 2028. It is estimated to register a CAGR of 19.6% from 2022 to 2028. Regional...
August 2023
115 pages
